SHARE NOW
WATCH ON DEMAND | MEET THE PANEL
Wondering how to overcome challenges to access cell and gene therapies? Are FDA approvals a topic of concern when mitigating your timeline? Perhaps understanding how the ‘lottery’ of patient availability might affect access to treatment?
There are a number of factors that can contribute to disparities in access to cell and gene therapies, including FDA approvals, physical location, financial insurance coverage and patient availability.
The impact these disparities have on patient access and outcomes can be detrimental to the key progression of developing and commercializing advanced therapies. Patients who are unable to access these therapies may be at a disadvantage in receiving potentially life-changing treatments.
Join us as a panel of experts discusses the disparities in access to cell and gene therapies and ways in which solutions can implemented and be accounted for. The panel of industry leaders will also share insights into topics that contribute to the factors that may hinder access to cell and gene therapy.
WHAT TO EXPECT
Part 1: The panel will discuss key areas that create disparities in access to cell and gene therapy which include:
- FDA approvals – discussing timelines and FDA-approved therapies
- Physical location – more centers to help alleviate cumbersome equipment in hospital settings, and more access points for patients to receive cell collection and reinfusion.
- Financial coverage
- Insurance coverage – how increased hospital implementation can lead to more widely accepted insurance rates and payments
- Availability of therapies for patients – more accessibility and affordability will lead to less need for complexities associated with triage
- The impact these disparities have on patient access and outcomes
Part 2: The speakers answer audience questions with an interactive Q&A.
MEET THE PANEL
Cate Spears
CEO
CGT Global, previously known as StemExpress
Andrew Branagan
Medical and Laboratory Director
CGT Global, previously known as StemExpress
George Eastwood
Board Chair/Interim Executive Director
Emily Whitehead Foundation
Sara Cobb
Clinical Nurse Manager for Cellular Therapy
Massachusetts General Hospital
This webinar is brought to you in partnership with CGT Global, previously known as StemExpress
